Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 20, 2021

SELL
$85.24 - $94.15 $205,684 - $227,183
-2,413 Closed
0 $0
Q1 2021

Apr 19, 2021

SELL
$83.5 - $98.47 $157,230 - $185,419
-1,883 Reduced 43.83%
2,413 $206,000
Q4 2020

Jan 19, 2021

BUY
$78.07 - $94.43 $5,855 - $7,082
75 Added 1.78%
4,296 $406,000
Q3 2020

Oct 20, 2020

SELL
$82.14 - $91.0 $21,356 - $23,660
-260 Reduced 5.8%
4,221 $367,000
Q2 2020

Jul 16, 2020

SELL
$80.93 - $91.1 $32,776 - $36,895
-405 Reduced 8.29%
4,481 $391,000
Q1 2020

Apr 21, 2020

SELL
$70.67 - $99.01 $69,256 - $97,029
-980 Reduced 16.71%
4,886 $403,000
Q4 2019

Jan 21, 2020

BUY
$84.35 - $95.37 $2,530 - $2,861
30 Added 0.51%
5,866 $555,000
Q3 2019

Oct 22, 2019

SELL
$85.54 - $94.26 $4,619 - $5,090
-54 Reduced 0.92%
5,836 $507,000
Q2 2019

Jul 29, 2019

BUY
$75.4 - $92.8 $113,100 - $139,200
1,500 Added 34.17%
5,890 $538,000
Q1 2019

Apr 19, 2019

SELL
$75.32 - $86.15 $24,253 - $27,740
-322 Reduced 6.83%
4,390 $422,000
Q4 2018

Jan 17, 2019

SELL
$73.66 - $82.02 $55,834 - $62,171
-758 Reduced 13.86%
4,712 $404,000
Q3 2018

Oct 12, 2018

SELL
$66.94 - $77.43 $33,470 - $38,715
-500 Reduced 8.38%
5,470 $471,000
Q2 2018

Jul 11, 2018

SELL
$64.91 - $73.36 $21,420 - $24,208
-330 Reduced 5.24%
5,970 $451,000
Q4 2017

Jan 16, 2018

SELL
$72.33 - $77.64 $23,507 - $25,233
-325 Reduced 4.91%
6,300 $529,000
Q3 2017

Oct 16, 2017

BUY
$74.14 - $77.27 $491,177 - $511,913
6,625
6,625 $569,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Blb&B Advisors, LLC Portfolio

Follow Blb&B Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blb&B Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blb&B Advisors, LLC with notifications on news.